Medtech

  • Group launches to become permanent home for Britain’s founder-led medtech firms

    A new investment group has launched with the aim of buying and permanently holding successful British medtech companies, offering their founders an alternative to selling to private equity firms or larger rivals. Qualeris, based in Birmingham, was founded by Peter Dines, a medtech chief executive, investor and board director with three decades of experience in [...]

  • Antimicrobial resistance innovation secures commercial partner

    AseptiFlow has secured a commercial partner as the NHS-developed device moves towards wider deployment in healthcare settings worldwide. The device, invented and developed by Dr James Soothill, consultant microbiologist at Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), has been licensed to Mueller Europe Ltd for commercial manufacture and adoption across hospitals, care [...]

  • New Zealand approves use of MDMA for severe PTSD

    New Zealand has approved MDMA for treating severe PTSD, becoming the second country after Australia to permit its use for the condition. The approval was granted by New Zealand's pharmaceutical regulator, Medsafe, and follows Australia's 2023 decision to approve psychedelics for PTSD and treatment-resistant depression. Two psychiatrists have been authorised to prescribe pharmaceutical-grade [...]

  • Elekta secures €100 million EIB loan

    Elekta has secured a loan of up to €100m to support a roughly €200m research programme focused on cancer and neurological treatment technologies. The Stockholm-based medical technology company plans to carry out the research programme between 2026 and 2029, with most of the work based in Sweden and the Netherlands. The financing will support work [...]

  • London surgeons perform world-first AI-assisted brain tumour surgery

    London surgeons have performed what health officials described as the first successful AI-assisted brain tumour operation, helping save a patient's sight. The surgery was carried out in May on 48-year-old Rhys Hibbert, who had an 11mm tumour on his pituitary gland and faced losing his sight without an operation, health officials said. During the procedure, [...]

  • Start-up wins £75,000 to develop calming tech for dementia and palliative care

    Health tech start-up Souuthe has secured £75,000 to develop dementia tech for people living with dementia and receiving palliative care. The Saltburn-by-the-Sea business has been awarded an Innovate UK Women in Innovation Award, with founder Lou Willis-Keeler selected as one of 61 entrepreneurs from a record 1,590 applicants nationwide. The business is developing calming technology [...]

  • KKR to take Integer private in US$5.7bn deal

    KKR will take Integer Holdings private in an all-cash US$5.7bn deal, expanding its healthcare portfolio with the medical device supplier. Shares in the Plano, Texas-based company rose 2.6 per cent in early trading. Integer makes components and finished products used by medical device companies in cardiovascular and neuromodulation therapies, among other applications.   [...]

  • HeroSupport opens first US site for SHIELD study

    Geneva-based HeroSupport has announced that NYU Grossman School of Medicine is the first US clinical site in its SHIELD study of VENUS SHELL. Professor Naamit Gerber will serve as principal investigator. Gerber is professor and vice-chair of education in the department of radiation oncology at NYU Grossman School of Medicine.   She is [...]

  • Heart drug approved for thousands of NHS patients with serious condition

    Around 6,600 people in England will gain access to the drug aficamten following simultaneous MHRA authorisation and NICE approval. The once-daily tablet, also known as MYQORZO, is for people with symptomatic obstructive hypertrophic cardiomyopathy. Known as obstructive HCM, the condition causes the heart muscle to become thick and stiff, making it harder to pump blood [...]

  • The hidden IP risks of EUDAMED

    By Kieran Killough, partner, HGF Limited For many years, medical device companies operated in a regulatory environment where significant product and compliance information was held within national systems and was therefore difficult for competitors to access. The European Database on Medical Devices (EUDAMED) changes that landscape. Developed under the EU Medical Device Regulation (MDR) and [...]